Supervisory Board

Governance / Supervisory Board

Members of the Supervisory Board

Chairman H.H. Kloos RBA (1957)

Mr. Kloos studied at the Nyenrode Business University and has a degree in Investment and Financial Analysis from the Free University Amsterdam. Mr. Kloos currently holds the following appointments:

  • Managing director a.i. Mayflower Project (USA)
  • Chairman of the renumeration committee for analysts at the Dutch Securities Institute
  • Member of the Advisory Board at De Medici Vermogensbeheer
During the last five years Mr. Kloos also held the following appointments:
  • Managing Director a.i. Robein
  • Supervisory director at ASVB
  • Consultant for De Nederlandsche Bank 
Mr. Kloos was appointed on 19 June 2014 for a period of four years.

Drs. B. Vos (1939)

Dr. Vos graduated in Medicine at the University of Groningen.

Dr. Vos currently holds the following appointments:

  • Chaiman of the Oversight Committee at Kempen Capital Management 
  • Independent entrepreneur
  • Chairman of the Supervisory Board of Middle Europe Opportunity Fund II N.V.
  • Chairman of the Supervisory Board of Middle Europe Opportunity Fund III N.V.

During the past five years Dr. Vos has also held the following appointments:

  • Vice-Chairman of Koninklijke Reesink N.V.
  • Member of the Supervisory Board of Corio N.V.
  • Independent consultant
  • Chairman of the Supervisory Board of Orange European Property Fund N.V.
  • General Director at Bedrijfsvereniging Detam (now Riadiaal B.V.)
  • Member of the Management Board at De Boer Unigro N.V. (now Jumbo Supermarkten B.V.)
  • Chairman of the Board at HEMA B.V. 
  • General Director NOC/NSF
  • Managing Director Henderson French Property Fund 
  • CEO Taxi Centrale Amsterdam
  • Chairman of the Supervisory Board of Russian Midcap Fund N.V. i.l.
  • Chairman of the Supervisory Board of Emerging Europe Equity Fund N.V. i.l.

Dr. Vos has been a member of the Supervisory Board since 19 May 2009. His current appointment will end on 19 June 2018.

Shares held by Supervisory Board members

Dr Vos holds 8,958 shares of the Arcona Property Fund.

The dividend policy for Arcona Property Fund is to pay at least 35% of the annual direct result as a dividend. The target is, within a three to five year time frame from end 2016, to increase annual dividend payments to a level of 8% of the prevailing share price.

Arcona Property Fund counts the following substantial companies amongst its tenants: